1 The FLOW trial achieved its primary endpoint with Ozempic 1 mg, demonstrating a statistically significant and superior 24% relative risk reduction of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease (4.9% absolute risk reduction at 3 years) compared to placebo, when added to standard of care
In the SUSTAIN program, acute kidney failure was only reported in SUSTAIN 6, where its occurrence was similar between semaglutide and placebo (28)
How Does Semaglutide Help With Weight Loss
The three pathways include: GIP receptor GLP-1 receptor Glucagon receptor This triple action explains why many people compare retatrutide vs semaglutide and tirzepatide
14) Whats included in the $75/week weight loss program
Ozempic alternatives for weight loss Despite its popularity for those looking to lose weight, Ozempic is actually not approved by the FDA for weight loss